Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:38904rdf:typepubmed:Citationlld:pubmed
pubmed-article:38904lifeskim:mentionsumls-concept:C0021080lld:lifeskim
pubmed-article:38904lifeskim:mentionsumls-concept:C0144047lld:lifeskim
pubmed-article:38904pubmed:issue9lld:pubmed
pubmed-article:38904pubmed:dateCreated1979-11-29lld:pubmed
pubmed-article:38904pubmed:abstractTextSulfato-trans-(-)-1,2-diaminocyclohexane platinum(II) is a new antitumor agent. Its effect on immune responses was investigated. This agent inhibited lymphocyte transformation in response to phytohemagglutinin, pokeweed mitogen, and concanavalin A. It inhibited antibody plaque-forming spleen cells in AKR/J mice at doses ranging from 2.5 to 7.5 mg/kg i.p. It also prolonged the survival of skin grafts against major histocompatibility barriers in C57BL/6J mice transplanted with tail skin from CBA/J mice. The effective dose ranged from 2.5 to 5 mg/kg. This compound inhibited graft-versus-host reaction in three-week-old AKR/J X DBA/2JF1 mice receiving spleen cells from AKR/J mice i.p. Significant inhibition of graft-versus-host reaction was seen with doses ranging from 1 to 7.5 mg/kg i.p. These results suggest that this drug is immunosuppressive.lld:pubmed
pubmed-article:38904pubmed:languageenglld:pubmed
pubmed-article:38904pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38904pubmed:citationSubsetIMlld:pubmed
pubmed-article:38904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38904pubmed:statusMEDLINElld:pubmed
pubmed-article:38904pubmed:monthSeplld:pubmed
pubmed-article:38904pubmed:issn0008-5472lld:pubmed
pubmed-article:38904pubmed:authorpubmed-author:HillJ MJMlld:pubmed
pubmed-article:38904pubmed:authorpubmed-author:KhanAAlld:pubmed
pubmed-article:38904pubmed:authorpubmed-author:HoganSSlld:pubmed
pubmed-article:38904pubmed:issnTypePrintlld:pubmed
pubmed-article:38904pubmed:volume39lld:pubmed
pubmed-article:38904pubmed:ownerNLMlld:pubmed
pubmed-article:38904pubmed:authorsCompleteYlld:pubmed
pubmed-article:38904pubmed:pagination3476-8lld:pubmed
pubmed-article:38904pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-An...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Mi...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Im...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Sp...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Cy...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Fe...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Hy...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Ly...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Do...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-An...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Im...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Mi...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Mi...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Gr...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Mi...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Mi...lld:pubmed
pubmed-article:38904pubmed:meshHeadingpubmed-meshheading:38904-Or...lld:pubmed
pubmed-article:38904pubmed:year1979lld:pubmed
pubmed-article:38904pubmed:articleTitleImmunosuppressive effects of sulfato-trans-(-)-1,2-diaminocyclohexaneplatinum(II).lld:pubmed
pubmed-article:38904pubmed:publicationTypeJournal Articlelld:pubmed